ASBP: Aspire Biopharma Holdings, Inc. - Summary | Jitta

Aspire Biopharma Holdings, Inc.

NASDAQ:ASBP

Price
$6.03
Loss Chance
59.1%
n/aJITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Sorry, the data is not yet available for this stock.
Jitta Factors
Growth Opportunity (10)
Recent Business Performance (19)
Financial Strength (27)
Return to Shareholders (22)
Competitive Advantage (19)
Jitta Signs
Debt LevelLow Long Term Debt
Cash Conversion CycleLess than 30 days
Recent Business PerformanceEarning decline 105.87% in the last quarter (yoy)
Key Stats
Jitta Score
Jitta Line
n/a
100.00%
3.05
96.13%
3.05
206.95%
Pharmaceuticals
4.95
53.81%
5.05
79.87%
5.69
90.15%
COMPANY DESCRIPTION
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.